Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Forecasting

How Poor Forecasting Impacts U.S. Drug Commercialization
Posted in
  • Strategy & Execution

How Poor Forecasting Impacts U.S. Drug Commercialization

U.S. prescription drug spending reached nearly $722 billion in 2023, according to CMS data available at https://data.cms.gov. … How Poor Forecasting Impacts U.S. Drug CommercializationRead more

by Jayshree Gondane•March 4, 2026March 4, 2026•0

Recent Posts

  • Why Life Sciences Companies Struggle With Digital Adoption
  • How Poor Forecasting Impacts U.S. Drug Commercialization
  • Why Many Pharma Launches Miss Revenue Targets in the U.S. Market
  • How Omnichannel Marketing Is Reshaping U.S. Pharma Sales Strategy
  • Why Scientific Messaging Fails to Connect With Physicians

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A